BET-IN-14

BET-IN-14 is an orally active pan BET inhibitor (IC50: 5.35 nM) . BET-IN-14 has anti-cancer activity[1].

Product Specifications

CAS Number

[2243669-93-2]

UNSPSC

12352005

Target

Epigenetic Reader Domain

Type

Reference compound

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/bet-in-14.html

Purity

99.07

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CC1=CC=C(N2C(C3=CC(N(C4CCCC4)[C@H](C)C(N5C)=O)=C5C=C3)=NC(C(N6CCN(C)CC6)=O)=N2)C=C1

Molecular Formula

C30H37N7O2

Molecular Weight

527.66

References & Citations

[1]Damaneh MS, et al. A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction. Invest New Drugs. 2020 Jun;38 (3) :700-713.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

PV010464 500 ng

CPB2 Protein Vector (Human) (pPM-C-His)

View Details

NBP2-12103AF594 0.1 mL

Mouse Monoclonal CCL21/6Ckine Antibody (MM0146-2H26) [Alexa Fluor 594]

View Details

MBS9617511-01 1 mg

HSL Blocking Peptide

View Details

MBS9617511-02 5x 1 mg

HSL Blocking Peptide

View Details

NBL1-12142 0.1 mg

KCNB1 Overexpression Lysate (Native) - (Dry Ice)

View Details

MBS2615592-01 48 Well

Rat Fibroblast Growth Factor 5 (FGF5)

View Details